(Q55056515)

PubMed publication ID

22837179

16 June 2018

http://europepmc.org/abstract/MED/22837179

title

Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

6

Steven A Rosenberg

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

author name string

Simon Turcotte

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

John R Wunderlich

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

Mojgan Ahmadzadeh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

Mark E Dudley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

language of work or name

English

0 references

publication date

26 July 2012

1 reference

PubMed publication ID

22837179

16 June 2018

http://europepmc.org/abstract/MED/22837179

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

page(s)

5212-5223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

Clinical significance of defective dendritic cell differentiation in cancer

13 May 2020

cites work

1 reference

12 December 2020

Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer

1 reference

12 December 2020

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

1 reference

12 December 2020

Tumour-educated macrophages promote tumour progression and metastasis

1 reference

12 December 2020

Down-regulation of HLA class II and costimulatory CD86/B7-2 on circulating monocytes from melanoma patients

1 reference

12 December 2020

Eosinophils: 'new' roles for 'old' cells

1 reference

12 December 2020

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

12 December 2020

2B4 (CD244) is expressed and functional on human eosinophils

1 reference

12 December 2020

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

1 reference

12 December 2020

Regulation of immune responses by L-arginine metabolism

1 reference

12 December 2020

Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host

1 reference

12 December 2020

B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma

1 reference

12 December 2020

Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells

1 reference

12 December 2020

Highly purified selective isolation of eosinophils from human peripheral blood by negative immunomagnetic selection

1 reference

12 December 2020

Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

1 reference

12 December 2020

Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy

1 reference

12 December 2020

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

1 reference

12 December 2020

Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells

1 reference

12 December 2020

Lung carcinoma associated with excessive eosinophilia

1 reference

12 December 2020

Immunoregulatory roles of eosinophils: a new look at a familiar cell

1 reference

12 December 2020

FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions

1 reference

12 December 2020

Subsets of myeloid-derived suppressor cells in tumor-bearing mice

1 reference

12 December 2020

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

12 December 2020

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

1 reference

12 December 2020

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

1 reference

12 December 2020

Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma.

1 reference

12 December 2020

Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor.

1 reference

12 December 2020

Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer

1 reference

12 December 2020

Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma

1 reference

12 December 2020

Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer

1 reference

12 December 2020

Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF.

1 reference

12 December 2020

Myeloid-derived suppressor cell heterogeneity and subset definition.

1 reference

12 December 2020

Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone

1 reference

12 December 2020

Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign

1 reference

12 December 2020

Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression

1 reference

12 December 2020

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

1 reference

12 December 2020

Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A

1 reference

12 December 2020

Myeloid derived suppressor cells in human diseases

1 reference

12 December 2020

In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site

1 reference

12 December 2020

Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells

1 reference

12 December 2020

Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4⁺ T cells from patients with GI malignancy

1 reference

12 December 2020

Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13.

1 reference

12 December 2020

A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.

1 reference

12 December 2020

Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice

1 reference

12 December 2020

Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model

1 reference

12 December 2020

Failure to detect production of IL-10 by activated human neutrophils

1 reference

12 December 2020

CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function

1 reference

12 December 2020

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

1 reference

12 December 2020

CTLA-4 blockade with ipilimumab: long-term follow-up of 177 patients with metastatic melanoma

1 reference

12 December 2020

Tumour-associated eosinophilia: a review

1 reference

12 December 2020

Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2

1 reference

12 December 2020

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

12 December 2020

Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor.

1 reference

12 December 2020

10.1158/1078-0432.CCR-12-1108

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6374773&resulttype=core&format=json

13 May 2020

PubMed publication ID

22837179

1 reference